KAKEN PHARMACEUTICAL CO., LTD.
科研製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4521
FY2025 · 2026-03-31
| Gross margin | 52.0% |
| Operating margin | -1.2% |
| Net margin | 2.8% |
| Return on equity | 1.6% |
| Return on assets | 1.2% |
| Revenue growth (YoY) | -18.3% |
| EPS (basic) | ¥56.57 |
| EPS growth (YoY) | -84.5% |
| Current ratio | 4.52x |
| Equity ratio | 76.9% |
| Book value / share | ¥3,898.24 |
| Free cash flow | -14,075 M |